Clinical features of the DMD patients ordered by increasing age.

<p>Clinical features of the DMD patients ordered by increasing age.</p

Patient flow-chart.

<p>Patient flow-chart.</p

Reliability between test and retest for all the tasks evaluated for each ActiMyo^® variable.

<p><b>◇</b> MoviPlate; <b>⬜</b> BBT; <b>△</b> Minnesota test; <b>✱</b> Writing;<b>×</b> PC typing.</p

The tools.

<p><b>(A)</b> First version of ActiMyo^®, used in the current study. <b>(B)</b> Box and Block test. <b>(C)</b> Minnesota test with five discs.</p

The maximal scores on tasks completed by each patient at the two visits sorted by the decreasing age.

<p>The maximal scores on tasks completed by each patient at the two visits sorted by the decreasing age.</p

Correlation between the ActiMyo^® variables and the functional scores.

<p>Correlation between the ActiMyo^® variables and the functional scores.</p

Clinical data of all DMD patients sorted by age.

<p>* patients previously published.</p><p>§ patients who accomplished the 12-month visits.</p><p>CS—corticosteroids use; H—height (cm), W—weight (kg), FVC—forced vital capacity (% of predicted value), ID—intellectual disability, LOA—age at loss of ambulation (months), LVEF—left ventricular ejection fraction (%), NA—not available, SS- spine surgery.</p><p>Clinical data of all DMD patients sorted by age.</p

Sample size estimation per group in a clinical trial to detect an improvement stabilization of strength or MoviPlate score on the dominant (D) side.

<p>≥3y-MoviPlate-D—patients with duration since loss of ambulation of 3 years or more.</p><p>Sample size estimation per group in a clinical trial to detect an improvement stabilization of strength or MoviPlate score on the dominant (D) side.</p

Flow chart of patients included in the clinical protocol.

<p>Flow chart of patients included in the clinical protocol.</p

Clinical and functional data at baseline.

<p>Clinical and functional data at baseline.</p